Cochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research Program
Cochlear, based in Sydney, has recently finished recruiting participants for its global pivotal trial assessing fully implantable hearing technology. Patients enrolled in Cochlear’s research programs have collectively logged over 1 million hours with the device. This milestone highlights the extensive research endeavors dedicated to fully implantable hearing technology, emphasizing Cochlear's unwavering dedication to advancing this innovative field. The program signals a significant step forward in enhancing hearing capabilities.